⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0002070437

Boucher Kelley

Reports to the SEC for 1 company · WALTHAM, MA

Transactions

19

Companies

1

Filings

5

CIK

0002070437

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-14	APLSApellis Pharmaceuticals, Inc.D Disposition to Issuer	Chief People Officer	DDisposition to Issuer	−45.1K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc. · Stock Option (right to buy)D Disposition to Issuer	Chief People Officer	DDisposition to Issuer	−45.8K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc. · Stock Option (right to buy)D Disposition to Issuer	Chief People Officer	DDisposition to Issuer	−67.4K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc. · Stock Option (right to buy)D Disposition to Issuer	Chief People Officer	DDisposition to Issuer	−33K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc.D Disposition to Issuer	Chief People Officer	DDisposition to Issuer	−30.1K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc.D Disposition to Issuer	Chief People Officer	DDisposition to Issuer	−30.5K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc.U Disposition from Tender	Chief People Officer	UDisposition from Tender	−128K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc.A Award	Chief People Officer	AAward	+15.1K sh	—	—	15,073
2026-05-14	APLSApellis Pharmaceuticals, Inc.D Disposition to Issuer	Chief People Officer	DDisposition to Issuer	−15.1K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc.A Award	Chief People Officer	AAward	+30.1K sh	—	—	30,146
2026-05-14	APLSApellis Pharmaceuticals, Inc.D Disposition to Issuer	Chief People Officer	DDisposition to Issuer	−30.1K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc.D Disposition to Issuer	Chief People Officer	DDisposition to Issuer	−22.1K sh	—	—	0
2026-01-28	APLSApellis Pharmaceuticals, Inc.A Award	Chief People Officer	AAward	+30.1K sh	—	—	127,804
2025-09-02	APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief People Officer	AAward	+45.8K sh	—	—	45,766
2025-09-02	APLSApellis Pharmaceuticals, Inc.A Award	Chief People Officer	AAward	+30.5K sh	—	—	97,658
2025-06-09	APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief People Officer	AAward	+67.4K sh	$19.39	+$1.31M	67,396
2025-06-09	APLSApellis Pharmaceuticals, Inc.A Award	Chief People Officer	AAward	+45.1K sh	—	—	67,182
2025-05-28	APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief People Officer	AAward	+33K sh	$16.80	+$554K	32,976
2025-05-28	APLSApellis Pharmaceuticals, Inc.A Award	Chief People Officer	AAward	+22.1K sh	—	—	22,087

Recent filings

5

Accepted (ET)
May 144
Boucher Kelley0001193125-26-224589
SEC(opens sec.gov)
Jan 304
Boucher Kelley0001492422-26-000079
SEC(opens sec.gov)
Sep 34
Boucher Kelley0001127602-25-021104
SEC(opens sec.gov)
Jun 114
Boucher Kelley0001127602-25-017286
SEC(opens sec.gov)
May 294
Boucher Kelley0001127602-25-015877
SEC(opens sec.gov)

Companies

1

Apellis Pharmaceuticals, Inc.Chief People OfficerAPLS

Address

C/O APELLIS PHARMACEUTICALS, INC. 100 FIFTH AVENUE, 3RD FLOOR

WALTHAM, MA, 02451